Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
Resource Type
Erratum
Authors
Miyazaki, Isao ; Odintsov, Igor ; Ishida, Keiji ; Lui, Allan J. W. ; Kato, Masanori ; Suzuki, Tatsuya ; Zhang, Tom ; Wakayama, Kentaro ; Kurth, Renate I. ; Cheng, Ryan ; Fujita, Hidenori ; Delasos, Lukas ; Vojnic, Morana ; Khodos, Inna ; Yamada, Yukari ; Ishizawa, Kota ; Mattar, Marissa S. ; Funabashi, Kaoru ; Chang, Qing ; Ohkubo, Shuichi ; Yano, Wakako ; Terada, Ryuichiro ; Giuliano, Claudio ; Lu, Yue Christine ; Bonifacio, Annalisa ; Kunte, Siddharth ; Davare, Monika A. ; Cheng, Emily H. ; de Stanchina, Elisa ; Lovati, Emanuela ; Iwasawa, Yoshikazu ; Ladanyi, Marc ; Somwar, Romel
Source
Nature Cancer . 4(10):1526-1526
Subject
Language
English
ISSN
2662-1347